Are Opioids Effective in Relieving Neuropathic Pain?

Abstract

Neuropathic pain (NP) and its treatment are considered to constitute an unmet need, with a high-multidimensional impact on society and the sufferer. The broad spectrum of opioid analgesics is considered beneficial for acute pain, yet these drugs pose serious controversial issues due to the potential for adverse behavior and a higher chance of tolerance and addiction in long-term use. Opioids like other first-line medications for NP, will not be useful for every patient suffering from chronic NP. However, due to their possible adverse effects, opioids are considered as second-or third-line medications by various guidelines. Therefore, this literature review was conducted to evaluate the status of opioids in NP and to asses if any recent research has shed further evidence on their efficacy or the contrary. The literature reviewed showed that the mechanisms underlying NP, may themselves contribute to the reduced effect of opioids in this condition. Also, various genetic polymorphisms affecting pharmacokinetic and pharmacodynamic factors are discussed, providing further evidence for the variability in opioid response. Although opioids may reduce NP, nociceptive pain tends to be more responsive to opioids compared to NP. Also, opioids seem to be more effective in intermediate term studies of up to 12 weeks and being mostly effective in peripheral NP compared to supraspinal NP and being least effective in central NP. However, there is still no robust evidence that any specific opioid agent is better than any other one for NP, but it is possible that opioids targeting multiple mechanisms may provide benefit. A limitation of many trials is the lack of consideration for the comorbid psychological aspects of NP, which tend to lower opioid analgesia.

The blockade of CC chemokine receptor type 1 influences the level of nociceptive factors and enhances opioid analgesic potency in a rat model of neuropathic pain

“…Approximately 5-10% of the population worldwide suffers from neuropathic pain. 1,2 This pathological state is caused by a lesion or disease of the somatosensory nervous system, which can result from injury or a medical condition such as cancer, diabetes or autoimmune diseases. 1,3 The treatment of neuropathic pain is still challenging.…”

Pitfals in recognition and management of trigeminal neuralgia

“…It is worth underlining that, before the diagnosis, patients had been formally prescribed or were taking symptomatic drugs according to a self-medication regimen, with little or no benefit, especially from the NSAID class and opioids for acute attacks. There is indeed evidence for a limited effect of opioids in neuropathic pain in general [25]. Only a minority of patients had been prescribed anti-epileptic drugs, of the class of gabapentinoids, before the diagnosis.…”

Common Cancers Among Kurdish People in the Northwest of Iran: Current Status and Future Prospects

“…Fortunately, most cancers are very curable diseases when founds early and treated [51]. Specialists need to consider the challenge of managing cancer pain in a patient over a potentially longer duration, as cancer is no longer considered a terminal disease [52,53].…”